The mechanism of action and biodistribution of a novel EGFR/VEGF bispecific fusion protein that exhibited superior antitumor activities

Despite the promising clinical benefits of therapies targeting epidermal growth factor receptor (EGFR) or vascular endothelial growth factor (VEGF) with antibodies in various cancers, resistance to these therapies will inevitably develop following treatment. Recent studies suggest that crosstalk bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Lan, Wang, Lihua, Zhang, Jinzhao, Zhao, Le, Meng, Yun, Zheng, Jidai, Xu, Wei, Zhu, Zhenping, Huang, Haomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360952/
https://www.ncbi.nlm.nih.gov/pubmed/37484224
http://dx.doi.org/10.1016/j.heliyon.2023.e16922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360952/
https://www.ncbi.nlm.nih.gov/pubmed/37484224
http://dx.doi.org/10.1016/j.heliyon.2023.e16922

Ejemplares similares